| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chunguang Zhang CEO | HKEX Exchange | G4644W106 CUSIP |
| Hong Kong Country | 90 Employees | - Last Dividend | - Last Split | - IPO Date |
Huakang Biomedical Holdings Company Limited operates as an investment holding conglomerate with a specialized focus on the healthcare sector, specifically in the field of in-vitro diagnostics (IVD). Founded in 1992 and headquartered in Tsim Sha Tsui, Hong Kong, the company has carved a niche in the research, development, manufacture, marketing, and sale of IVD reagents. Its operations span across the People's Republic of China, including Hong Kong, and extend up to Canada. Huakang Biomedical Holdings Company Limited is dedicated to enhancing diagnostic methodologies and healthcare solutions, providing a significant contribution to medical institutions and distributors directly, with a strong portfolio of products recognized for their innovation and reliability.